Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Assets
QFR223385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
1,802,549.00
Year-over-Year Change
9.01%
Date Range
10/1/2000 - 4/1/2025
Summary
This trend tracks the total assets of U.S. pharmaceutical and medicine corporations on a quarterly basis, providing insights into the financial health and scale of the industry. It serves as a key indicator of sector-wide investment, growth potential, and economic performance.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The total assets metric reflects the cumulative value of resources owned by pharmaceutical companies, including physical infrastructure, intellectual property, cash reserves, and investment holdings. Economists use this trend to assess industry capitalization, investment capacity, and potential for future innovation and expansion.
Methodology
Data is collected through comprehensive financial reporting by corporations, aggregated and verified by the U.S. Federal Reserve using standardized accounting principles.
Historical Context
This trend is critical for analyzing sectoral economic performance, investment attractiveness, and potential impacts on healthcare innovation and national economic strategy.
Key Facts
- Represents comprehensive financial snapshot of U.S. pharmaceutical corporate assets
- Quarterly data provides dynamic view of sector's economic performance
- Includes tangible and intangible assets across pharmaceutical corporations
FAQs
Q: What does 'total assets' include in this context?
A: Total assets encompass physical properties, cash reserves, intellectual property, investments, and other financial resources owned by pharmaceutical corporations.
Q: How frequently is this data updated?
A: The data is updated quarterly, providing a current and dynamic view of the pharmaceutical sector's financial landscape.
Q: Why are pharmaceutical corporate assets important?
A: These assets indicate the sector's capacity for research, development, innovation, and potential economic contribution.
Q: How do total assets relate to corporate performance?
A: Total assets reflect a company's financial strength, investment potential, and ability to generate future revenue and innovation.
Q: What limitations exist in this data?
A: The data provides a snapshot of assets but does not directly indicate profitability, market performance, or future growth potential.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Aerospace Products and Parts: Land and Mineral Rights
QFR217386USNO
Quarterly Financial Report: U.S. Corporations: Aerospace Products and Parts: Inventories
QFR214386USNO
Quarterly Financial Report: U.S. Corporations: Petroleum and Coal Products: Property, Plant, and Equipment
QFR216324USNO
Quarterly Financial Report: U.S. Corporations: Communications Equipment: Retained Earnings
QFR322384USNO
Quarterly Financial Report: U.S. Corporations: Food: All Other Operating Costs and Expenses
QFR103311USNO
Quarterly Financial Report: U.S. Corporations: Chemicals: Long-Term Debt, Due in More Than 1 Year: Other Long-Term Loans
QFRD319CHEUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Assets [QFR223385USNO], retrieved from FRED.
Last Checked: 8/1/2025